![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Walsh J.K.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.11, Iss.5, 1999-05, pp. : 393-394
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Colesevelam: A Viewpoint by James Shepherd
By Shepherd J.
American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Desloratadine: A Viewpoint by James H. Day and Elizabeth Rafeiro
Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Recombinant Full-Length Parathyroid Hormone (1-84): A Viewpoint by James Whitfield
Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. :